Related Experiment Videos
Future developments in the selectivity of anticancer agents: drug delivery and molecular target strategies
1Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada. lmayer@bccancer.bc.ca
Abstract:
In the past, our limited understanding of the processes involved in the initiation and growth of cancer hindered our ability to effectively treat most human malignancies and therapies were often associated with significant toxic side effects as well as re-emergence of disease. The development of drug delivery systems such as liposomes has improved the specificity of various conventional anticancer agents by enhancing drug accumulation in tumors while often decreasing exposure to susceptible healthy tissues. More recently, the identification of a wide range of genes and corresponding protein products that are altered in various human cancers has revealed new molecular targets for cancer therapy that may provide improved selectivity for tumor cells over traditional cytotoxic agents. This review discusses how advances in the sophistication of liposomal delivery systems may open new opportunities for combining novel molecular targeting strategies with pharmacological targeting via liposomes to optimize the therapy of many human malignancies.
Insights
Liposomes enhance anticancer drug delivery, improving tumor targeting and reducing side effects. Combining liposomal delivery with new molecular targets offers optimized cancer therapy strategies.
Area of Science:
- Oncology
- Nanomedicine
- Pharmacology
Background:
- Limited understanding of cancer initiation and growth historically hindered effective treatment.
- Conventional therapies often caused significant toxic side effects and disease re-emergence.
- Liposomes have improved anticancer agent specificity by enhancing tumor drug accumulation and reducing healthy tissue exposure.
Purpose of the Study:
- To review advances in liposomal delivery systems for cancer therapy.
- To explore the integration of novel molecular targeting with liposomal drug delivery.
- To optimize human malignancy treatment through combined targeting strategies.
Main Methods:
- Review of current literature on liposomal drug delivery systems.
- Analysis of molecular targets identified in human cancers.
- Discussion of strategies for combining molecular and pharmacological targeting.
Main Results:
- Liposomal systems enhance the specificity of conventional anticancer agents.
- Identification of numerous molecular targets offers new therapeutic avenues.
- Sophisticated liposomal delivery systems facilitate combination strategies.
Conclusions:
- Advances in liposomal technology enable synergistic approaches in cancer treatment.
- Combining molecular targeting with liposomal delivery promises improved therapeutic outcomes.
- Optimized cancer therapy can be achieved by integrating novel strategies with advanced drug delivery systems.